Table 2

Use of indications, level of care and demography from Sweden

Total
(n=31 632)
Sweden
(n=20 833)
Norway
(n=10 294)
West Jutland, Denmark
(n=505)
Main indication
 Obstruction16 278 (51.5%)12 953 (62.2%)3185 (31.0%)140 (27.7%)
 Recurrent tonsillitis7350 (23.3%)3489 (16.7%)3664 (35.7%)197 (39.0%)
 Peritonsillitis1310 (4.1%)1090 (5.2%)184 (1.8%)36 (7.1%)
 Chronic tonsillitis5993 (19.0%)2867 (13.8%)3062 (29.8%)64 (12.7%)
 Other indication615 (1.9%)434 (2.1%)164 (1.6%)17 (3.4%)
 Foetor ex ore50 (0.2%)0050 (9.9%)
 Missing360351
Sex
 Male15 020 (47.5%)10 489 (50.3%)4337 (42.1%)194 (38.4%)
 Female16 612 (52.5%)10 344 (49.7%)5957 (57.9%)311 (61.6%)
Age at surgery14.2 (12.6)13 (12.5)16.3 (12.2)20.8 (13.2)
Mean (SD)/median (Min; Max)9 (0; 88)7 (0; 88)17 (0; 80)19 (1; 68)
Nn=31 632n=20 833n=10 294n=505
Level of care
 Outpatient24 234 (77.7%)15 942 (78.1%)7897 (76.8%)395 (78.2%)
 Inpatient6971 (22.3%)4482 (21.9%)2379 (23.2%)110 (21.8%)
 Missing427409180
  • Norway and Denmark for tonsillectomy and tonsillotomy with or without adenoidectomy.